In the past week, AGL stock has gone down by -44.86%, with a monthly decline of -61.47% and a quarterly plunge of -42.36%. The volatility ratio for the week is 17.77%, and the volatility levels for the last 30 days are 10.98% for Agilon Health Inc The simple moving average for the past 20 days is -53.26% for AGL’s stock, with a -73.38% simple moving average for the past 200 days.
Is It Worth Investing in Agilon Health Inc (NYSE: AGL) Right Now?
The 36-month beta value for AGL is at 0.10. Analysts have varying views on the stock, with 2 analysts rating it as a “buy”, 0 rating it as “overweight”, 13 as “hold”, and 0 as “sell”.
The public float for AGL is 304.15M, and currently, shorts hold a 6.63% of that float. The average trading volume for AGL on February 12, 2026 was 8.17M shares.
AGL stock’s latest price update
The stock price of Agilon Health Inc (NYSE: AGL) has plunged by -15.63% when compared to previous closing price of $0.45, but the company has seen a -44.86% decline in its stock price over the last five trading sessions.
Analysts’ Opinion of AGL
Many brokerage firms have already submitted their reports for AGL stocks, with Bernstein repeating the rating for AGL by listing it as a “Mkt Perform”. The predicted price for AGL in the upcoming period, according to Bernstein is $1.40 based on the research report published on August 20, 2025 of the previous year 2025.
Citigroup, on the other hand, stated in their research note that they expect to see AGL reach a price target of $1. The rating they have provided for AGL stocks is “Neutral” according to the report published on August 06th, 2025.
Bernstein gave a rating of “Outperform” to AGL, setting the target price at $8.50 in the report published on April 08th of the previous year.
AGL Trading at -50.35% from the 50-Day Moving Average
After a stumble in the market that brought AGL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -93.75% of loss for the given period.
Volatility was left at 10.98%, however, over the last 30 days, the volatility rate increased by 17.77%.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AGL starting from Wulf John William, who purchase 81,000 shares at the price of $0.63 back on Nov 12 ’25. After this action, Wulf John William now owns 365,857 shares of Agilon Health Inc, valued at $50,941 using the latest closing price.
Stock Fundamentals for AGL
Current profitability levels for the company are sitting at:
- -0.06% for the present operating margin
- -0.02% for the gross margin
The net margin for Agilon Health Inc stands at -0.05%. The total capital return value is set at -1.05%. Equity return is now at value -73.31%, with -17.51% for asset returns.
Based on Agilon Health Inc (AGL), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at -1.85. The debt to equity ratio resting at 0.12. The interest coverage ratio of the stock is -57.46.
Currently, EBITDA for the company is -$218.19 million with net debt to EBITDA at 0.47. When we switch over and look at the enterprise to sales, we see a ratio of 0.0. The receivables turnover for the company is 6.21for trailing twelve months and the total asset turnover is 3.69. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.08.
Conclusion
In conclusion, Agilon Health Inc (AGL) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.